About IRIX Pharmaceuticals
IRIX Pharmaceuticals is a Healthcare company based in Florence (United States) founded in 1996, and was acquired by Patheon in March 2015. Difficult-to-manufacture APIs and complex intermediates are developed by IRIX Pharmaceuticals. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.
Company details
IRIX Pharmaceuticals was established in 1996 in Florence, United States, as a contract research and manufacturing organization in the pharmaceutical sector. It was acquired by Patheon in 2015. Services encompass process research, development, and production of challenging active pharmaceutical ingredients from preclinical stages through commercial manufacturing, including stability studies and regulatory support. Operations extend to clients across North America, Europe, Asia, and Australia.
- Headquarters Florence, United States
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website irixpharma.com
- Social LinkedIn
- Acquired by Patheon (Mar 2015)
Investors in IRIX Pharmaceuticals
IRIX Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Patheon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | 1974 | patheon.com | Durham, United States |
Investor details for IRIX Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IRIX Pharmaceuticals
2 dated milestones of IRIX Pharmaceuticals across 19 years, from founding to its latest funding, stage changes and deals.
- Founded IRIX Pharmaceuticals is founded.
- Exit Acquired by Patheon.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as IRIX Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IRIX Pharmaceuticals
IRIX Pharmaceuticals was founded in 1996.
IRIX Pharmaceuticals is headquartered in Florence, United States.
IRIX Pharmaceuticals was established in 1996 in Florence, United States, as a contract research and manufacturing organization in the pharmaceutical sector. It was acquired by Patheon in 2015. Services encompass process research, development, and production of challenging active pharmaceutical ingredients from preclinical stages through commercial manufacturing, including stability studies and regulatory support. Operations extend to clients across North America, Europe, Asia, and Australia.
IRIX Pharmaceuticals has 1 investor. Key investors include Patheon.
Yes. IRIX Pharmaceuticals was acquired by Patheon in March 2015.
